PetLife Finalizes Negotiations for Dr. Geoff’s Real Food for Pets

Guía de Regalos

Product line of 25 supplements and pet accessories to roll out across
the country

HANCOCK, Md.–(BUSINESS WIRE)–PetLife
Pharmaceuticals, Inc.
(OTCQB: PTLF) (the “Company”), a developer of
a new generation of high-potency veterinary cancer medications and
nutraceuticals for pets, announced today that it has finalized the
negotiations for the acquisition of Dr. Geoff’s Real Food for Pets™. The
closing of the acquisition of the trademarked brands and the natural pet
food product line is projected to occur within two weeks.

PetLife has expanded plans for a national rollout to the public by
Summer 2017 with canned food and two Superfood Supplements, ImmunoPower™
and Antioxidant Boost™, which should have many benefits for companion
pets. PetLife will, over time, roll out a complete product line of 25
foods, treats, supplements, and pet accessories. These include
nutraceuticals, shampoos, creams, sprays, and other natural products
(i.e., supplements) for dogs and cats.

“According to a March 2017 IBISWorld report, rising disposable income,
coupled with the tendency for family members to treat pets like family
members and an increase in wanting to feed their pets all-natural food,
are expected to increase profits for all-natural pet product providers
over the next five years,” said Ralph Salvagno, CEO of PetLife
Pharmaceuticals. “Additionally, the number of pet-owning households is
expected to grow from the current 65% of U.S. households that currently
own a dog, increasing the potential consumer demand for Dr. Geoff’s Real
Food for Pets™.”

Dr. Geoff’s Real Food for Pets™ already includes six SKUs of
retail-ready products, including both canned food and antioxidant
supplements. Since 1969, renowned veterinarian Dr. Geoffrey Broderick
has been a pioneer in the premium, natural pet food industry.

Geoffrey Broderick, Jr., the son of Dr. Broderick, has resigned as
President of the Company in order to focus on the development of the
Company’s new subsidiary, Dr. Geoff’s by PetLife, Inc. He will bring his
experience in the pet food industry and should be instrumental in the
Company’s pet product subsidiary as our products go to market, where his
focus will be on product distribution channels, the related marketing
program, and manufacturing, in line with our anticipated growth.

About PetLife Pharmaceuticals, Inc.

PetLife Pharmaceuticals, Inc. (PTLF)
(www.PetLifePharma.com)
is a registered U.S. Veterinary Pharmaceutical company. PetLife’s
mission is to bring its new, scientifically-proven, non-toxic,
potentiated bioactive nutraceuticals and prescription medication,
VitalZul™, to the world of veterinary oncology with the ultimate goal of
preventing cancer and extending the life of pets suffering from cancer
while improving their quality of life. In the U.S. alone, consumer
spending on domestic companion animals reached over $60 billion in 2015
with over $29 billion spent on veterinary care and medications.

Forward-looking statement:

This press release contains certain “forward-looking statements,” as
defined in the United States Private Securities Litigation Reform Act of
1995, that involve a number of risks and uncertainties. There can be no
assurance that such statements will prove to be accurate and the actual
results and future events could differ materially from management’s
current expectations. The economic, competitive, governmental,
technological and other factors identified in the Company’s previous
filings with the Securities and Exchange Commission may cause actual
results or events to differ materially from those described in the
forward-looking statements in this press release. The Company undertakes
no obligation to publicly update or revise any forward-looking
statements, whether as a result of new information, future events or
otherwise.

Contacts

PetLife Pharmaceuticals, Inc.
Clifford Price, 844-473-8543
ext. 701
clifford@petlifepharma.com
or
Press
Contact:

Leigh Minnier, 610-228-2108
leigh@gregoryfca.com